These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19892322)

  • 1. Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.
    Hinrichs AL; Mintun MA; Head D; Fagan AM; Holtzman DM; Morris JC; Goate AM
    Biol Psychiatry; 2010 Mar; 67(6):581-3. PubMed ID: 19892322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
    Morris JC; Roe CM; Xiong C; Fagan AM; Goate AM; Holtzman DM; Mintun MA
    Ann Neurol; 2010 Jan; 67(1):122-31. PubMed ID: 20186853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.
    Weigand SD; Vemuri P; Wiste HJ; Senjem ML; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS; Jack CR;
    Alzheimers Dement; 2011 Mar; 7(2):133-41. PubMed ID: 21282074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
    Swaminathan S; Risacher SL; Yoder KK; West JD; Shen L; Kim S; Inlow M; Foroud T; Jagust WJ; Koeppe RA; Mathis CA; Shaw LM; Trojanowski JQ; Soares H; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
    Alzheimers Dement; 2014 Jan; 10(1):e9-e18. PubMed ID: 23541187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease.
    Grimmer T; Goldhardt O; Yakushev I; Ortner M; Sorg C; Diehl-Schmid J; Förstl H; Kurz A; Perneczky R; Miners S
    Neurodegener Dis; 2019; 19(1):43-50. PubMed ID: 31266021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.
    Villeneuve S; Vogel JW; Gonneaud J; Pichet Binette A; Rosa-Neto P; Gauthier S; Bateman RJ; Fagan AM; Morris JC; Benzinger TLS; Johnson SC; Breitner JCS; Poirier J;
    JAMA Neurol; 2018 May; 75(5):608-619. PubMed ID: 29482212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC
    Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
    Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS
    Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
    Grimmer T; Riemenschneider M; Förstl H; Henriksen G; Klunk WE; Mathis CA; Shiga T; Wester HJ; Kurz A; Drzezga A
    Biol Psychiatry; 2009 Jun; 65(11):927-34. PubMed ID: 19268916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD.
    Shimada H; Ataka S; Takeuchi J; Mori H; Wada Y; Watanabe Y; Miki T
    J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):123-6. PubMed ID: 21750305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.
    Apostolova LG; Hwang KS; Andrawis JP; Green AE; Babakchanian S; Morra JH; Cummings JL; Toga AW; Trojanowski JQ; Shaw LM; Jack CR; Petersen RC; Aisen PS; Jagust WJ; Koeppe RA; Mathis CA; Weiner MW; Thompson PM;
    Neurobiol Aging; 2010 Aug; 31(8):1284-303. PubMed ID: 20538372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.